This newly engineered OVV showed IFN-dependent cancer selectivity and efficacy in both tumor cells and tumor-associated vascular endothelial cells in vitro, and tumor targeting and efficacy in in vivo mouse models (89). Here, IFNA1 is linked to neoplasm.